Personalized Physical Back Training Program to Improve Physical Functioning in People With Non-specific Low Back Pain
LIFDI
2 other identifiers
interventional
180
1 country
1
Brief Summary
Personalized medicine and individualized therapeutic approaches are prominent in current research. But are these approaches also effective for treating non-specific low back pain (NSLBP)? NSLBP is one of the most common musculoskeletal issues, which can impair physical well-being, reduce the quality of life, and limit physical functioning. Additionally, it contributes to substantial direct and indirect healthcare costs, such as frequent doctor visits and work absences. Despite NSLBP being a significant burden for both individuals and society, effective alleviation methods remain unclear. The investigators' research project therefore aims to investigate whether personalized therapy, specifically a personalized physical back training program, can effectively address NSLBP. Within the context of NSLBP, the investigators' specific aim is to improve physical functioning as this outcome is considered relevant from all perspectives, including those of patients, clinical professionals, researchers, and guidelines.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2025
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 14, 2025
CompletedFirst Posted
Study publicly available on registry
April 22, 2025
CompletedStudy Start
First participant enrolled
May 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2027
May 4, 2025
May 1, 2025
2.6 years
April 14, 2025
May 1, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Self-rated physical functioning
Change in Patient-Specific Functional Scale (PSFS), most bothersome activity. Range from 0 (unable to perform due to NSLBP) to 100 (able to perform at the same level as before NSLBP)
Baseline to 12 weeks
Secondary Outcomes (6)
Self-rated physical functioning
Baseline to 4, 8, and 24 weeks
Self-rated physical functioning (RMDQ)
Baseline to 4, 8, 12, and 24 weeks
Health-related quality of life (EQ-VAS)
Baseline to 4, 8, 12, and 24 weeks
Health-related quality of life (EQ-5D-5L)
Baseline to 4, 8, 12, and 24 weeks
Pain intensity (NRS)
Baseline to 4, 8, 12, and 24 weeks
- +1 more secondary outcomes
Other Outcomes (5)
Pain frequency
Baseline to 4, 8, 12, and 24 weeks
Pain duration
Baseline to 4, 8, 12, and 24 weeks
Pain interference (PEG)
Baseline to 4, 8, 12, and 24 weeks
- +2 more other outcomes
Study Arms (2)
Personalized back exercises
EXPERIMENTALThe study intervention is a 12-week personalized physical back training program. It consists of six to eight exercises selected from a predefined set by a physical therapist or medical doctor. These exercises are selected through a clinical reasoning process, i.e., they are tailored and problem-oriented, based on the results of a clinical assessment.
Non-personalized back exercises
ACTIVE COMPARATORThe active control intervention is a 12-week non-personalized physical back training program. It consists of six to eight exercises selected from a predefined set by a physical therapist or medical doctor. These exercises are not selected through a clinical reasoning process, i.e., they are neither tailored nor problem-oriented nor based on the results of a clinical assessment.
Interventions
The study intervention is a 12-week personalized physical back training program. It consists of six to eight exercises selected from a predefined set by a physical therapist or medical doctor. These exercises are selected through a clinical reasoning process, i.e., they are tailored and problem-oriented, based on the results of a clinical assessment. An initial one-on-one training session will take place to familiarize participants with the back training program, corresponding to the first week's session of the 12-week intervention period. During the 12-week intervention period, the training comprises one supervised group session per week, lasting 30 minutes, along with three individual unsupervised sessions, each lasting 10-15 minutes. Our procedures ensures that both participants and instructors are blinded to the group allocation, allowing both groups to train together (e.g., mixed training groups).
The active control intervention is a 12-week non-personalized physical back training program. It consists of six to eight exercises selected from a predefined set by a physical therapist or medical doctor. These exercises are not selected through a clinical reasoning process, i.e., they are neither tailored nor problem-oriented nor based on the results of a clinical assessment. An initial one-on-one training session will take place to familiarize participants with the back training program, corresponding to the first week's session of the 12-week intervention period. During the 12-week intervention period, the training comprises one supervised group session per week, lasting 30 minutes, along with three individual unsupervised sessions, each lasting 10-15 minutes. Our procedures ensures that both participants and instructors are blinded to the group allocation, allowing both groups to train together (e.g., mixed training groups).
Eligibility Criteria
You may qualify if:
- Access to the University Sports of the Lucerne Universities (i.e., students, employees, alumni, subscribers)
- NSLBP for at least 6 weeks
- Activity limiting NSLBP (at least one activity with a PSFS Score of ≤ 50/100 on a scale from 0 = unable to perform due to NSLBP to 100 = able to perform at the same level as before NSLBP)
- Age between 18 and 65 years
- Understand the German language
- Willing to participate in the study
- Written informed consent
You may not qualify if:
- Specific LBP
- Red flags associated with any serious pathology or specific LBP,
- Being on a waiting list for or less than 12 months post any surgery of the lower back
- Pregnancy or given birth within the last 12 months
- Diagnosed central neurological disease
- Not allowed to exercise
- Participant in the feasibility study
- Expecting to be absent for more than 2 weeks during the intervention period
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Claudio Perretlead
Study Sites (1)
University of Lucerne, Faculty of Health Sciences and Medicine, University Research Centre Health and Society
Lucerne, Canton of Lucerne, 6002, Switzerland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Claudio Perret, PhD
University of Lucerne, University Research Centre Health and Society
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Prof. Dr. Claudio Perret
Study Record Dates
First Submitted
April 14, 2025
First Posted
April 22, 2025
Study Start
May 1, 2025
Primary Completion (Estimated)
December 1, 2027
Study Completion (Estimated)
December 1, 2027
Last Updated
May 4, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- It is anticipated that the data will be made available as soon as possible after the completion of the study and will remain accessible for at least 10 years.
- Access Criteria
- Access to the data will be granted in accordance with the criteria of the repository and/or publisher.
It is anticipated that the investigators will make encrypted individual participant data (IPD) available via a data repository and, additionally, upon reasonable request to the Principal Investigator. In both cases, only data from participants who have provided informed consent for data sharing will be made available.